Feature Scientus enters commercialization stage of growth, readies launch of lead product By Len Zehr Closely-held Scientus Pharma expects to launch its first cannabis soft gel capsules for the treatment of neuropathic pain at the end of the year, to be followed in early 2018 with a soft gel for epilepsy and... August 1, 2017